KMT2D, an epigenetic regulator that mediates germinal center B-cell development under physiological conditions and leads to lymphomagenesis when disrupted (43), was shown to be mutated in CD5+ DLBCL, mostly with nonsense mutations. The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.